Evidera’s interventional study team, made up of dedicated peri- and post-approval experts, can design and execute efficient, fit-for-purpose studies that help you meet regulator requirements and achieve optimal commercialization. With deep knowledge of post-market requirements and endpoints, our experienced team can navigate those requirements to position your product for future success.
Dedicated Team, Global Power
Our team leverages the global power, therapeutic expertise, and deep clinical development experience of PPD to seamlessly transition earlier phase studies to late-phase studies. We utilize PPD’s network of physicians and product development experts to execute studies focused on operational excellence. With extensive experience across all interventional study types, we can execute cost-effective trials across the globe drawing on our experience in more than 70 countries, including China and Japan.